Device type · DIP
Enzyme Immunoassay, Diphenylhydantoin
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
DIP
Clinical Toxicology
Device class
Class II
FDA decisions since 2015
0
510(k), De Novo and PMA
Adverse event reports
24
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Enzyme Immunoassay, Diphenylhydantoin
- Product code
- DIP
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3350
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for DIP
Latest FDA decisions
No 510(k), De Novo or PMA decisions for this product code since 2015.
Reports received
24
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
24
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 7 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 5 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 1 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 1 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 1 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 1 | 0 | 0 | 0 |
| Jul 26 | 3 | 0 | 0 | 0 |
| Aug 26 | 5 | 0 | 0 | 0 |
| Sep 26 | 14 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- High Test Results17
- Low Test Results11
- Incorrect, Inadequate or Imprecise Result or Readings1
- Non Reproducible Results1
- Output Problem1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions24
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Ortho-Clinical Diagnostics, Inc.
Z-1136-2021 · Started Jan 14, 2021
Reason given: A deformity affecting a specific lot of VITROS Chemistry Products VersaTips. Deformed VersaTips results may be biased by up to +/-16% for both immunometric and competitive assays.
Cause as FDA categorized it: Under Investigation by firm
Z-2344-2018 · Started May 9, 2018
Reason given: There is a potential for imprecise results when using the slides. Increase in imprecision when using PHYT coating 0165. This leads to higher and lower than expected results for both quality control samples and patient samples.
Cause as FDA categorized it: Under Investigation by firm
Z-0273-2018 · Started Jun 12, 2017
Reason given: The firm identified the potential for biased results to be generated when processing VITROS PHYT Slide product with citrate plasma specimen samples. The current Instructions for Use (IFU) and Assay Summary Chart state serum, heparin plasma, and citrate plasma as acceptable specimen types for use with the PHYT assay.
Cause as FDA categorized it: Device Design
Siemens Healthcare Diagnostics, Inc.
Z-0148-2015 · Started Sep 24, 2014 · Posted by FDA Oct 29, 2014
Reason given: Internal testing has confirmed a low absorbance range between the levels 1 and 5 calibrators with this lot resulting in the potential for a positive or negative bias and imprecision across the PTN assay range.
Cause as FDA categorized it: Under Investigation by firm
Z-0007-2015 · Started Aug 20, 2014 · Posted by FDA Oct 2, 2014
Reason given: Ortho Clinical Diagnostics identified a potential for biased results to be generated when using VITROS PHYT Slides, Lot 2613-0150-4913. Some positively biased results were identified during testing of a different VITROS PHYT Slide lot; the affected slides were not released for distribution. Since Lot 2613-0150-4913...
Cause as FDA categorized it: Software Manufacturing/Software Deployment
Siemens Healthcare Diagnostics, Inc
Z-0929-2014 · Started Dec 18, 2013 · Posted by FDA Feb 4, 2014
Reason given: ADVIA Centaur Systems Phenytoin Calibrator N, lots CN58 and higher, change in recovery observed with the ADVIA Centaur Systems Phenytoin assay compared to recoveries using previous Calibrator N lots.
Cause as FDA categorized it: Under Investigation by firm
Siemens Healthcare Diagnostics, Inc
Z-0930-2014 · Started Dec 18, 2013 · Posted by FDA Feb 4, 2014
Reason given: ADVIA Centaur Systems Phenytoin Calibrator N, lots CN58 and higher, change in recovery observed with the ADVIA Centaur Systems Phenytoin assay compared to recoveries using previous Calibrator N lots.
Cause as FDA categorized it: Under Investigation by firm
Z-0321-2014 · Started Jun 12, 2013 · Posted by FDA Nov 15, 2013
Reason given: Ortho Clinical Diagnostics is recalling Slide Dispense cartridges used with some VITROS Chemistry Product Slides due to slide dispense issues.
Cause as FDA categorized it: Equipment maintenance
Showing the 8 newest of 11 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.